PHLDA1 is known to promote glioma progression, whereas miR-194 suppresses the proliferation and migration of glioma by regulating PHLDA1 (Liu et al. 2019; Wang et al. 2022a). This evidence concerns the gene PHLDA1 and central nervous system cancer.